Merck & Co., Inc. (MRK) 13D/13G Filings for PANDION THERAPEUTICS INC (PAND)

Merck & Co., Inc. 13D and 13G filings for PANDION THERAPEUTICS INC:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-03-11
3:19 pm
Sale
2024-03-11 13D PANDION THERAPEUTICS INC
PAND
MERCK SHARP & DOHME CORP.
MRK
1,000
100.000%
-3,079,815decrease
(-99.97%)
Filing
2024-01-17
5:48 pm
Purchase
2024-01-07 13D PANDION THERAPEUTICS INC
PAND
MERCK SHARP & DOHME CORP.
MRK
3,080,815
17.480%
3,080,815increase
(New Position)
Filing